» Articles » PMID: 35096987

E/E' Is a New Independent Predictor of Recovered Ejection Fraction in Patients With Systolic Heart Failure Undergoing Ablation for Atrial Fibrillation

Abstract

Catheter ablation should be considered in patients with atrial fibrillation (AF) and with heart failure (HF) with reduced ejection fraction (EF; HFrEF) to improve survival and reduce heart failure hospitalization. Careful patient selection for AF ablation is key to achieving similar outcome benefits. However, limited data exist regarding predictors of recovered ejection fraction. We aimed to evaluate the predictors of recovered ejection fraction in consecutive patients with HF undergoing AF ablation. A total of 156 patients [67.3% men, median age 63 (11)] with AF and HF underwent initial catheter ablation between September 2017 and October 2019 in the First Affiliated Hospital of Dalian Medical University. Overall, the percentage of recovered ejection fractions was 72.3%. Recovered EFs were associated with a 39% reduction in all-cause hospitalization compared to non-recovered EFs at the 1-year follow-up [23.8 vs. 62.8 (odds ratio) OR 2.09 (1.40-3.12), < 0.001]. Univariate analysis for recovered EFs showed that diabetes ( = 0.083), prevalent HF ( = 0.014), prevalent AF ( = 0.051), LVEF ( = 0.022), and E/E' ( = 0.001) were associated with EF improvement. Multivariate analysis showed that the only independent predictor of EF recovery was E/E' [OR 1.13 (1.03-1.24); = 0.011]. A receiver operating characteristic analysis determined that the suitable cut-off value for E/E' was 15 (sensitivity 38.7%, specificity 89.2%, the area under curve 0.704). Ejection fraction (EF) recovery occurred in 72.3% of patients, associated with a 39% reduction in all-cause hospitalization compared to the non-recovered EFs in our cohort. The only independent predictor of recovered EF was E/E' < 15 in our series.

Citing Articles

Predictors of Improvement in Left Ventricular Systolic Dysfunction in Patients with Atrial Fibrillation Undergoing Catheter Ablation: Systematic Review.

Ahluwalia N, Hussain A, Providencia R, Schilling R Arrhythm Electrophysiol Rev. 2025; 14:e02.

PMID: 40017669 PMC: 11865674. DOI: 10.15420/aer.2024.24.


Dilated nonischemic cardiomyopathy, amphetamines, and atrial fibrillation.

OHara J HeartRhythm Case Rep. 2024; 10(11):859-860.

PMID: 39664675 PMC: 11628815. DOI: 10.1016/j.hrcr.2024.10.011.


Premature Ventricular Contraction-Induced Cardiomyopathy: Contemporary Evidence from Risk Stratification, Pathophysiology, and Management.

Attachaipanich T, Thiravetyan B, Tribuddharat N, Jaroonpipatkul S, Navaravong L J Clin Med. 2024; 13(9).

PMID: 38731164 PMC: 11084868. DOI: 10.3390/jcm13092635.


Trajectory change of left ventricular ejection fraction after rhythm control for atrial fibrillation in heart failure.

Si J, Sun Y, Bai L, Tse G, Ding Z, Zhang X ESC Heart Fail. 2023; 11(2):681-691.

PMID: 38097279 PMC: 10966243. DOI: 10.1002/ehf2.14590.

References
1.
Gentlesk P, Sauer W, Gerstenfeld E, Lin D, Dixit S, Zado E . Reversal of left ventricular dysfunction following ablation of atrial fibrillation. J Cardiovasc Electrophysiol. 2006; 18(1):9-14. DOI: 10.1111/j.1540-8167.2006.00653.x. View

2.
Hindricks G, Potpara T, Dagres N, Arbelo E, Bax J, Blomstrom-Lundqvist C . 2020 ESC Guidelines for the diagnosis and management of atrial fibrillation developed in collaboration with the European Association for Cardio-Thoracic Surgery (EACTS): The Task Force for the diagnosis and management of atrial fibrillation of the.... Eur Heart J. 2020; 42(5):373-498. DOI: 10.1093/eurheartj/ehaa612. View

3.
Khan M, Jais P, Cummings J, Di Biase L, Sanders P, Martin D . Pulmonary-vein isolation for atrial fibrillation in patients with heart failure. N Engl J Med. 2008; 359(17):1778-85. DOI: 10.1056/NEJMoa0708234. View

4.
Knight B, Novak P, Sangrigoli R, Champagne J, Dubuc M, Adler S . Long-Term Outcomes After Ablation for Paroxysmal Atrial Fibrillation Using the Second-Generation Cryoballoon: Final Results From STOP AF Post-Approval Study. JACC Clin Electrophysiol. 2019; 5(3):306-314. DOI: 10.1016/j.jacep.2018.11.006. View

5.
Nery P, Thornhill R, Nair G, Pena E, Redpath C . Scar-based catheter ablation for persistent atrial fibrillation. Curr Opin Cardiol. 2016; 32(1):1-9. DOI: 10.1097/HCO.0000000000000349. View